These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7107009)

  • 1. Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.
    Wright PF; Belshe RB; Kim HW; Van Voris LP; Chanock RM
    Infect Immun; 1982 Jul; 37(1):397-400. PubMed ID: 7107009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
    Karron RA; Wright PF; Crowe JE; Clements-Mann ML; Thompson J; Makhene M; Casey R; Murphy BR
    J Infect Dis; 1997 Dec; 176(6):1428-36. PubMed ID: 9395351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
    Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL
    J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.
    Belshe RB; Van Voris LP; Mufson MA
    J Infect Dis; 1982 Mar; 145(3):311-9. PubMed ID: 7037983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
    Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR
    Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
    Wright PF; Shinozaki T; Fleet W; Sell SH; Thompson J; Karzon DT
    J Pediatr; 1976 Jun; 88(6):931-6. PubMed ID: 178852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.
    Herlocher ML; Ewasyshyn M; Sambhara S; Gharaee-Kermani M; Cho D; Lai J; Klein M; Maassab HF
    Vaccine; 1999 Jan; 17(2):172-81. PubMed ID: 9987152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children.
    McFarland EJ; Karron RA; Muresan P; Cunningham CK; Libous J; Perlowski C; Thumar B; Gnanashanmugam D; Moye J; Schappell E; Barr E; Rexroad V; Fearn L; Spector SA; Aziz M; Cielo M; Beneri C; Wiznia A; Luongo C; Collins P; Buchholz UJ
    J Infect Dis; 2020 Feb; 221(4):534-543. PubMed ID: 31758177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
    Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM
    Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children.
    Karron RA; Luongo C; Mateo JS; Wanionek K; Collins PL; Buchholz UJ
    J Infect Dis; 2020 Jun; 222(1):82-91. PubMed ID: 31605113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.
    Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization.
    Crowe JE; Bui PT; Siber GR; Elkins WR; Chanock RM; Murphy BR
    Vaccine; 1995 Jun; 13(9):847-55. PubMed ID: 7483808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
    Kim HW; Arrobio JO; Brandt CD; Wright P; Hodes D; Chanock RM; Parrott RH
    Pediatrics; 1973 Jul; 52(1):56-63. PubMed ID: 4353352
    [No Abstract]   [Full Text] [Related]  

  • 14. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.
    Rostad CA; Stobart CC; Gilbert BE; Pickles RJ; Hotard AL; Meng J; Blanco JCG; Moin SM; Graham BS; Piedra PA; Moore ML
    J Virol; 2016 Aug; 90(16):7508-7518. PubMed ID: 27279612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children.
    Karron RA; Luongo C; Thumar B; Loehr KM; Englund JA; Collins PL; Buchholz UJ
    Sci Transl Med; 2015 Nov; 7(312):312ra175. PubMed ID: 26537255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    Buchholz UJ; Cunningham CK; Muresan P; Gnanashanmugam D; Sato P; Siberry GK; Rexroad V; Valentine M; Perlowski C; Schappell E; Thumar B; Luongo C; Barr E; Aziz M; Yogev R; Spector SA; Collins PL; McFarland EJ; Karron RA;
    J Infect Dis; 2018 Apr; 217(9):1338-1346. PubMed ID: 29509929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
    J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.
    Wright PF; Karron RA; Belshe RB; Thompson J; Crowe JE; Boyce TG; Halburnt LL; Reed GW; Whitehead SS; Anderson EL; Wittek AE; Casey R; Eichelberger M; Thumar B; Randolph VB; Udem SA; Chanock RM; Murphy BR
    J Infect Dis; 2000 Nov; 182(5):1331-42. PubMed ID: 11010838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine.
    Yang CF; Wang CK; Malkin E; Schickli JH; Shambaugh C; Zuo F; Galinski MS; Dubovsky F; ; Tang RS
    Vaccine; 2013 Jun; 31(26):2822-7. PubMed ID: 23602668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.